US Patent Issued to RIKEN on July 14 for "Bioactive substance exhibiting antimalarial activity, and use for same" (Japanese, Egyptian Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,805, issued on July 14, was assigned to RIKEN (Saitama, Japan).

"Bioactive substance exhibiting antimalarial activity, and use for same" was invented by Hiroyuki Osada (Saitama, Japan), Takayuki Motoyama (Saitama, Japan), Islam Adel Abdelhakim (Assiut, Egypt) and Yushi Futamura (Saitama, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a compound represented by the following formula (I):and an antimalarial drug comprising the compound."

The patent was filed on March 3, 2022, under Application No. 18/278,325.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/neta...